Controversies in Management of Colorectal Peritoneal Carcinomatosis
Q & A/Discussion
Saturday, March 23, 2024
10:32am – 10:45am ET
Location: C101
Role of CRS/HIPEC metastatic colorectal cancer: Role of Neoadjuvant therapy for limited disease volume, Intraoperative Chemotherapy Consideration, Optimal surveillance and follow up, Emerging role of ctDNA in patient selection.